Patricia L. Kropf, MD

Clinical Locations

Primary Location

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111

Secondary Location

Fox Chase–Temple University Hospital Bone Marrow Transplant Program
Jeanes Hospital
Patient Care Center, Fifth Floor
7600 Central Avenue
Philadelphia, PA 19111


Associate Professor, Department of Hematology/Oncology

Deputy Director, Fox Chase-Temple University Hospital Bone Marrow Transplant Program

Leukemia and MDS TRDG Member

Lymphoma and CLL Cancer TRDG Member

NCCN, Acute Myeloid Leukemia Panel Member

NCCN, Chronic Myelogenous Leukemia Panel Member

NCCN, Myeloproliferative Neoplasms Panel Member


Research Program

Treatment Philosophy

I specialize in the care of patients with hematologic malignancies.  This includes patients with lymphoma, myelodysplasia, and acute leukemia. I attended Georgetown University School of Medicine and completed my medical training at the University of Pittsburgh Cancer Center where I specialized in the care of lymphoma patients with an emphasis on stem cell and bone marrow transplantation.  My clinical research focuses on the use of novel agents in the treatment of non-Hodgkin’s lymphoma as well as epigenetic therapy in myelodysplastic syndromes and acute leukemia.

I believe that each patient is unique and has their own background, and that each patient’s disease is different from anybody else’s disease. I want my patients to feel as though they are my most important patient.

I came to Fox Chase Cancer Center because I have great respect for the physicians there and because I wanted to become a part of its scientific community.  My involvement at Fox Chase allows me to focus on specialized patient care coupled with innovative clinical research. I feel privileged to be working at Fox Chase and look forward to seeing leukemia and lymphoma patients.

News: Epigenetic Therapy Tests at Fox Chase

Dr. Patricia Kropf and Dr. Jean-Pierre Issa, a researcher at Fox Chase, are testing the next generation of epigenetic therapy, using genes to fight cancer. It’s being funded by Stand Up To Cancer. Stephanie Stahl and CBSPhilly filed a report on the benefits of one such trialSeptember 4, 2014

Education, Training & Credentials

Educational Background

  • Fellow, Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, 2009 
  • Resident, Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, 2006 
  • MD, Georgetown University School of Medicine, Washington, DC, 2003


  • Hematology
  • Medical Oncology
  • Internal Medicine
  • American Board of Internal Medicine, 2006


  • National Comprehensive Cancer Network (NCCN)
    • Chronic Myelogenous Leukemia Panel
    • Myeloproliferative Neoplasms Panel
Patient Stories

Brian Kozera


Brian Kozera


As my arms sliced through the surface of the cool, turquoise, waters of Austria’s Lake Wörthersee, I couldn’t believe that this moment had arrived. Just two years earlier, in 2014, my world was turned upside down when I was diagnosed with cancer.

Research Profile

Research Program

Research Interests

  • Allogeneic and Autologous Stem-Cell Transplants for Hematologic Malignancies
  • Mini-Allogeneic Stem-Cell Transplants
  • Acute Myelogenous Leukemia